EVIO Inc. (OTCQB: EVIO) Expands California Operations, Acquires 100% of Leaf Detective, LLC
Premiere cannabis testing laboratory acquires facility in Humboldt County, CA., to fulfill surge in demand as July 1 deadline approaches
Bend, Oregon - April 30, 2018 (Newsfile Corp.) (Investorideas.com Newswire) EVIO Inc. (OTCQB: EVIO) ("EVIO" or "the Company") a leading provider of cannabis testing and scientific research for the regulated cannabis industry, is pleased to announce that it has executed an asset purchase agreement to acquire 100% of California-based testing lab, Leaf Detective, LLC.
Leaf Detective, Humboldt County's first licensed cannabis testing facility, is an independently owned and operated testing facility dedicated to providing accurate results in a timely manner. The lab specializes in analytical laboratory testing for medical marijuana dispensaries, cannabis manufacturers, producers and consumers.
Due to California's July 1 testing deadline mandating licensed retailers to sell only lab tested product, the industry is predicting a shortage of testing services and delays in getting approval to sell the products. This strategic acquisition is part of EVIO's efforts to further expand into the state to meet increasing demand for analytical testing services.
"Leaf Detective holds one of only 28 licenses issued by the Bureau of Cannabis Control to testing facilities. Upon completion of this acquisition, we will upgrade the facility to meet new testing standards and plan to be operational by end of third quarter," said William Waldrop, CEO of EVIO Inc. "Our goal is to continue to improve consumer safety and increase shareholder value by capturing additional market share."
A recent report from industry research firm, BDS Analytics, estimates that California cannabis sales will reach $3.7 billion by the end of 2018 and predicts an increase to $5.1 billion in 2019. Leaf Detective is located in the Emerald Triangle region, the largest cannabis-producing region in the United States, giving EVIO increased exposure to clientele.
Pursuant to the Agreement, EVIO Inc., will form a new entity, EVIO Labs Humboldt, to purchase 100% of Leaf Detective business assets including equipment, brand, customer lists, customer contracts, rental agreements, and equipment leases for total consideration of US$500,000 in a Convertible Promissory Note, convertible at $1.25 per share.
About EVIO, Inc.
EVIO, Inc. is a leading provider of cannabis testing and scientific research for the regulated cannabis industry. The Company's EVIO Labs division operates coast-to-coast providing state-mandated ancillary services to ensure the safety and quality of the nation's cannabis supply. EVIO is on track to have 18 of its state-of-the-art testing facilities by year-end 2018.
For more information, visit www.eviolabs.com.
About Leaf Detective, LLC.
Leaf Detective specializes in analytical laboratory testing for medical marijuana dispensaries, cannabis manufacturers, producers and consumers. Our services include cannabinoid profiling, microbial, residual solvent and pesticide testing for flower, trim, and all forms of concentrates including rosin, kief and shatter.
For more information, visit https://leafdetective.com.
Director of Marketing
New York, New York
North 6th Agency
Marijuana / Hemp Stocks
At Cannabisinvestorideas.com and Investorideas.com
Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/